HLA-A and hereditary clear cell renal cell carcinoma: After MHC-matched allergic nonogeneloablative allogeneic hematopoietic cell transplantation (HCT), induce T cell responses to HLA-A*0201 restricted secondary H antigen encoded by C19orf48 may contribute to regression of renal cell carcinoma.